(3S,9S,14aR)-9-benzyl-6,6-dicyclohexyl-3-((S)-7-hydroxy-6-oxooctyl)decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetraone

ID: ALA5203465

PubChem CID: 168293383

Max Phase: Preclinical

Molecular Formula: C38H56N4O6

Molecular Weight: 664.89

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](O)C(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)C(C2CCCCC2)(C2CCCCC2)NC1=O

Standard InChI:  InChI=1S/C38H56N4O6/c1-26(43)33(44)23-13-5-12-21-30-34(45)41-38(28-17-8-3-9-18-28,29-19-10-4-11-20-29)37(48)40-31(25-27-15-6-2-7-16-27)36(47)42-24-14-22-32(42)35(46)39-30/h2,6-7,15-16,26,28-32,43H,3-5,8-14,17-25H2,1H3,(H,39,46)(H,40,48)(H,41,45)/t26-,30-,31-,32+/m0/s1

Standard InChI Key:  MUOGWSZZDRMXBO-NKIORRDJSA-N

Molfile:  

 
     RDKit          2D

 49 53  0  0  0  0  0  0  0  0999 V2000
   -2.7258    4.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3133    3.3098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7242    2.5993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5432    2.5993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9541    3.3109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5468    4.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4918    3.3098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0811    2.5984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4918    1.8870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2032    1.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9147    1.8870    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2032    0.6548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4918    0.2441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0811   -0.4673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4918   -1.1786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2596   -0.4673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510   -1.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9725   -1.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3833   -1.8901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2047   -1.8901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6154   -2.6015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4369   -2.6015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8476   -1.8901    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8476   -3.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4369   -4.0243    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6691   -3.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510    0.2441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8624    0.6548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5738    0.2441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8624    1.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6145    1.1459    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.4641    2.0289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1335    2.7853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3356    2.7048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510    1.8870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2596    2.5984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510    3.3098    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0262    0.6548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4370   -0.0565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2584   -0.0565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6691    0.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2584    1.3662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4370    1.3662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6148   -0.0561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0346   -0.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2483   -1.4298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0418   -1.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6220   -1.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4083   -0.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  1  6  2  0
  7  2  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  6
 24 26  1  0
 16 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  1
 30 32  1  0
 32 33  1  0
 34 33  1  0
 35 34  1  0
 30 35  1  0
 36 35  1  0
  8 36  1  0
 36 37  2  0
 12 38  1  0
 39 38  1  0
 40 39  1  0
 41 40  1  0
 42 41  1  0
 43 42  1  0
 38 43  1  0
 12 44  1  0
 45 44  1  0
 46 45  1  0
 47 46  1  0
 48 47  1  0
 49 48  1  0
 44 49  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5203465

    ---

Associated Targets(Human)

HDAC4 Tclin Histone deacetylase 4 (2328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 664.89Molecular Weight (Monoisotopic): 664.4200AlogP: 4.12#Rotatable Bonds: 11
Polar Surface Area: 144.91Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.81CX Basic pKa: CX LogP: 4.79CX LogD: 4.79
Aromatic Rings: 1Heavy Atoms: 48QED Weighted: 0.26Np Likeness Score: 0.69

References

1. Qiu X, Zhu L, Wang H, Tan Y, Yang Z, Yang L, Wan L..  (2021)  From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.,  52  [PMID:34826681] [10.1016/j.bmc.2021.116510]

Source